SmarterDividends

MRK vs SYRE: Which Is the Better Dividend Stock?

As of Nov 22, 2026, MRK (Merck & Co., Inc.) screens as the stronger dividend stock, winning 3 of 3 head-to-head metrics. MRK offers the higher yield at 2.63%, MRK has the higher dividend-safety score.

Key facts: MRK vs SYRE

Data as of · Source: SmarterDividends data

  • As of Nov 22, 2026, Merck & Co., Inc. (MRK) has the higher forward dividend yield at 2.63%, versus 0.00% for Spyre Therapeutics, Inc. (SYRE).
  • By SmarterDividends' count as of Nov 22, 2026, MRK has raised its dividend for 15 consecutive years and SYRE for 0.
Cite this page

SmarterDividends, "MRK vs SYRE: Dividend Yield, Safety & Value Compared," updated Nov 22, 2026, https://smarterdividends.com/compare/mrk-vs-syre

MetricMRKSYRE
Forward yield2.63%0.00%
Annual dividend$3.52$0.00
Payout ratio343%—
Years of growth15 yr0 yr
5-yr dividend growth6.7%—
5-yr total return74%—
Dividend safety score87 (A)—
Fair value estimate$132.83—
Upside to fair value-1%—
Frequencyquarterly—
Market cap$329.7B$8.9B
P/E ratio135.1—

Higher yield

MRK

2.63%

Safer dividend

MRK

Grade A

Faster growth

MRK

6.7%

MRK vs SYRE FAQ

Is MRK or SYRE a better dividend stock?

On the data, MRK wins more head-to-head categories (3 vs 0). MRK offers the higher yield (2.63%), while MRK has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.

Which has a higher dividend yield, MRK or SYRE?

MRK has the higher forward dividend yield at 2.63%, versus 0.00% for SYRE.

Is MRK or SYRE safer?

Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.

See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.